Results 101 to 110 of about 188,005 (273)

A Scoping Review of Pathogenesis, Current Treatments, and Novel Approaches for Vitiligo

open access: yesJournal of Cosmetic Dermatology, Volume 24, Issue 10, October 2025.
ABSTRACT Background Vitiligo is a chronic skin disorder characterized by loss of melanocytes, causing depigmentation and psychological distress. Its pathogenesis is complex and multifactorial, involving genetic predisposition, autoimmune, oxidative stress, and neurogenic mechanisms.
Nusaibah Sallehuddin   +3 more
wiley   +1 more source

The Melanocortin System in Control of Inflammation

open access: yesThe Scientific World Journal, 2010
Melanocortin peptides, the collective term for α-, β-, and γ-melanocyte-stimulating hormone (α-, β-, γ-MSH) and adrenocorticotropic hormone (ACTH), are elements of an ancient modulatory system.
Anna Catania   +5 more
doaj   +1 more source

Is There a Rationale for the Use of an Alpha-Melanocyte-Stimulating Hormone Analog to Improve Gray Hair Repigmentation? [PDF]

open access: yesSkin Appendage Disord, 2023
Melo DF   +7 more
europepmc   +1 more source

Pinostrobin Suppresses the α-Melanocyte-Stimulating Hormone-Induced Melanogenic Signaling Pathway. [PDF]

open access: yesInt J Mol Sci, 2023
Athapaththu AMGK   +6 more
europepmc   +1 more source

Exploring FDA-Approved Frontiers: Insights into Natural and Engineered Peptide Analogues in the GLP-1, GIP, GHRH, CCK, ACTH, and α-MSH Realms

open access: yesBiomolecules
Peptides continue to gain significance in the pharmaceutical arena. Since the unveiling of insulin in 1921, the Food and Drug Administration (FDA) has authorised around 100 peptides for various applications.
Othman Al Musaimi
doaj   +1 more source

Home - About - Disclaimer - Privacy